Guiding growth through education: lessons learned in Clinical Trials | Episode 1 скачать в хорошем качестве

Guiding growth through education: lessons learned in Clinical Trials | Episode 1

In the first episode of the new series Guiding growth through education: lessons learned in Clinical Trials, SCDM 2025 Chair Carol Schaffer speaks with Dr. Sarah Brenner, Principal Deputy Commissioner of the FDA, to unpack one of the most important learning chapters in recent clinical research history: the COVID‑19 pandemic. Together, they reflect on how this period became an unprecedented classroom for the industry -forcing rapid experimentation, accelerating new models like decentralized trials, and challenging long‑held assumptions about how we capture, share, and interpret data. Dr. Brenner discusses not only the innovations that emerged, but the lessons we must carry forward: how to evaluate technology responsibly, how to stay anchored in patient needs, and how to turn crisis‑born creativity into lasting educational progress.